AI assistant
Sending…
MUSTANG BIO, INC. — Director's Dealing 2021
Mar 15, 2021
35167_dirs_2021-03-15_4b008096-bcf3-4d1e-87fb-68ae063414be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2020-12-15
Reporting Person: Achenbach Brian (SVP, Fin. & Corp. Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-15 | Common Stock | A | 22500 | — | Acquired | 151774 | Direct |
Footnotes
F1: Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc..
F2: Includes restricted stock units, which vest over various time periods.
More from MUSTANG BIO, INC.
Interim / Quarterly Report
2026
May 5
Delisting Announcement
2026
Apr 17
Major Shareholding Notification
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Proxy Solicitation & Information Statement
2025
Dec 3
Interim / Quarterly Report
2025
Nov 7